| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.78B | 5.27B | 3.98B | 606.00M | 238.00M | 176.00M |
| Gross Profit | 3.29B | 5.19B | 3.98B | 562.00M | 225.00M | 146.00M |
| EBITDA | 5.81B | 5.05B | 3.82B | 4.61B | 1.87B | 211.00M |
| Net Income | 6.28B | 5.04B | 3.84B | 4.57B | 1.85B | 214.00M |
Balance Sheet | ||||||
| Total Assets | 29.64B | 26.06B | 21.64B | 17.82B | 10.33B | 8.57B |
| Cash, Cash Equivalents and Short-Term Investments | 408.00M | 412.00M | 358.00M | 162.00M | 216.00M | 771.00M |
| Total Debt | 1.29B | 1.24B | 1.25B | 785.00M | 992.00M | 595.00M |
| Total Liabilities | 1.42B | 1.45B | 1.47B | 975.00M | 1.17B | 810.00M |
| Stockholders Equity | 28.23B | 24.61B | 20.17B | 16.84B | 9.16B | 7.76B |
Cash Flow | ||||||
| Free Cash Flow | 373.00M | 747.00M | 363.00M | 185.00M | -66.00M | 581.00M |
| Operating Cash Flow | 387.00M | 763.00M | 366.00M | 186.00M | -65.00M | 584.00M |
| Investing Cash Flow | 383.00M | -16.00M | -3.00M | 486.00M | -541.00M | -408.00M |
| Financing Cash Flow | -740.00M | -690.00M | -164.00M | -719.00M | 53.00M | -425.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £23.65B | 3.00 | 23.76% | 2.44% | 62.80% | 48.86% | |
78 Outperform | £4.15B | 5.71 | 41.35% | 5.93% | 4.28% | 5.18% | |
76 Outperform | £8.88B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £4.19B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
52 Neutral | £6.47B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% | |
48 Neutral | £13.52B | 30.04 | 6.81% | 8.29% | -38.98% | -31.14% |